Are you Dr. Dominy?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 29 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1001 Potrero Ave
Rm 7M
San Francisco, CA 94110Phone+1 415-206-5612Fax+1 415-206-8942
Summary
- Dr. Stephen Dominy, MD is a board certified psychiatrist in San Francisco, California. He is currently licensed to practice medicine in California and Ohio. He is affiliated with UCSF Medical Center and is an Associate Professor at UCSF School of Medicine.
Education & Training
- University of California (San Francisco)Residency, Psychiatry, 1995 - 1999
- Wright State University Boonshoft School of MedicineClass of 1995
Certifications & Licensure
- CA State Medical License 1997 - 2026
- OH State Medical License 1979 - 1995
- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 1 citationsUltrastructural localization of Porphyromonas gingivalis gingipains in the substantia nigra of Parkinson's disease brains.Florian Ermini, Victoria F Low, Jennifer J Song, Adelie Y S Tan, Richard L M Faull
NPJ Parkinson's Disease. 2024-04-25 - 13 citationsTreatment of Porphyromonas gulae infection and downstream pathology in the aged dog by lysine-gingipain inhibitor COR388.Shirin Arastu-Kapur, Mai Nguyen, Debasish Raha, Florian Ermini, Ursula Haditsch
Pharmacology Research & Perspectives. 2020-02-01 - 52 citationsAlzheimer's Disease-Like Neurodegeneration in Porphyromonas gingivalis Infected Neurons with Persistent Expression of Active Gingipains.Ursula Haditsch, Theresa Roth, Leo Rodriguez, Sandy Hancock, Thomas E. Cecere
Journal of Alzheimer's Disease. 2020-01-01
Press Mentions
- Cortexyme to Present New Data at AAIC 2021July 22nd, 2021
- Cortexyme Announces Partnership with Parkinson Study Group and Upcoming Alzheimer’s Disease Data PresentationMarch 8th, 2021
- Pfizer, Verily-Backed Alzheimer's Biotech Cortexyme Hit by FDA Partial Hold over Liver ToxicityFebruary 16th, 2021
- Join now to see all